Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

GSTC Globestar Therapeutics Corporation (PK)

0.00 (0.0%)
Dec 04 2023 - Closed
Delayed by 15 minutes


Draw Mode:

Volume 1,190,577
Bid Price 0.0013
Ask Price 0.0019
News -
Day High 0.0016


52 Week Range


Day Low 0.0014
Company Name Stock Ticker Symbol Market Type
Globestar Therapeutics Corporation (PK) GSTC OTCMarkets Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.0% 0.0016 16:20:45
Open Price Low Price High Price Close Price Prev Close
0.0015 0.0014 0.0016 0.0016
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
16 1,190,577 $ 0.001499 $ 1,785 - 0.0013 - 0.0241
Last Trade Time Type Quantity Stock Price Currency
15:24:34 5,000 $ 0.0016 USD

Globestar Therapeutics Corporation (PK) Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 1.40M 872.27M 446.54M - -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Globestar Therapeutics (PK) News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No GSTC Message Board. Create One! See More Posts on GSTC Message Board See More Message Board Posts

Historical GSTC Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.001450.00170.00140.00153933,619,6120.0001510.34%
1 Month0.001650.00220.00130.00151265,598,381-0.00005-3.03%
3 Months0.00290.00430.00130.00193785,729,042-0.0013-44.83%
6 Months0.003550.008150.00130.00268894,357,135-0.00195-54.93%
1 Year0.0120.02410.00130.00712914,439,654-0.0104-86.67%
3 Years0.0730.0730.00130.009353,871,217-0.0714-97.81%
5 Years0.0730.0730.00130.009353,871,217-0.0714-97.81%

Globestar Therapeutics (PK) Description

GlobeStar Therapeutics Corporation ("GlobeStar"), headquartered in Richland, Washington, was incorporated in 2016 and owns breakthrough addition of treatment for Multiple Sclerosis and other neurodegenerative diseases as well other pharmaceuticals and nutraceutical. GlobeStar is a clinical stage pharmaceutical company testing a worldwide patented formulation of 3 drugs previously approved by the FDA. Pre-clinical trials in Italy showed the drug combination was effective in the reduction of MS co-morbidities. GlobeStar is initiating discussions with the FDA on clinical trial design in the U.S. in preparation for FDA submission and approval.

Your Recent History

Delayed Upgrade Clock